Title | Purines and Myocardial Protection [electronic resource] / edited by Anwar-Saad A. Abd-Elfattah, Andrew S. Wechsler |
---|---|
Imprint | Boston, MA : Springer US, 1996 |
Connect to | http://dx.doi.org/10.1007/978-1-4613-0455-5 |
Descript | XXIV, 564 p. online resource |
I: Purine Metabolism in the Heart -- 1. Physiologic and Pathophysiologic Significance of Purine Metabolism in the Heart -- 2. Purine Metabolism in the Ischemic Canine and Human Immature Myocardium Deficient of 5?-Nucleotidase -- 3. Cardiac adenosine Metabolism: Physiological Implications -- 4. Purines Metabolism in Human Cardiomyocytes and Endothelium-Implications for Protection of the Heart during Cardiac Surgery -- 5. Assessment of Interstitial Fluid Adenosine: Implications for Exogenous or Endogenous and Endogenous Adenosine-Mediated Cardioprotection -- 6. Adenosine and Coronary Vascular Pharmacology -- 7. Alternations in Energy Substrate Metabolism during Oxidative Stress -- II: Myocardial Protection with Purines -- 8. Purines and Myocardial Protection: An Overview -- A. Myocardial Protection with Endogenous Purines -- 9. Nucleoside Transport Protein: Properties and Regulation -- 10. Role of Nucleoside Transport in Myocardial Injury and Protection: Separation Between Ischemic and Reperfusion Injury using a Selective Nucleoside Transport Blocker, p-Nitrobenzylthoinosine NBMPR -- 11. Myocardial Protection using Nucleoside Transport Inhibitors -- 12. Selective Blockade of Nucleoside Transport by NBMPR Attenuates Reperfusion-Mediated Ventricular Arrhythmias -- 13. Nucleoside Transport in the Human Myocardium -- 14. Selective Nucleoside Transport Blocker NBMPR Attenuates Myocardial Stunning in a Rabbit Model Deficient of Xanthine Oxidase -- 15. Amplification of Endogenous adenosine by โAdenosine Regulating Agentsโ as a Therapeutic Approach to the Treatment of Cardiac Ischemic Syndromes -- B. Myocardial Protection with Exongenous Purines -- 16. Organ Protection with ATP-Magnesium Chloride -- 17. Adenosine and Adenosine Receptor Protection of the Ischemic Heart -- 18. Effect of Adenosine on Myocardial stunning -- 19. Cardioprotection from Ischemic-Reperfusion Injury by Adenosine -- 20. Cardioprotection with Adenosine, inosine and Hypoxanthine -- 21. Adenosine and Adrenergic Mediated Effects in the Heart -- 22. Effects of Adenosine on Ventricular Tachycardia -- 23. Purines and Ventricular Arrhythmias -- 24. Adenosine and the Polymorphonuclear Leukocyte Function Mechanisms and Production -- 25. Purines and Regulation of Platelet Activation -- III: Purines and Myocardial Preconditioning -- 26. Myocardial Preconditioning: From a Model to a Phenomenon -- 27. ATP Metabolism and Ischemic Preconditioning -- 28. Do Adenosine A3 Receptors Cause Preconditioning? -- 29. KATP Channels and Adenosine Receptors and Ischemic Preconditioning -- 30. Role of Activation of Ecto-5?-Nucleotidase for Cardioprotection in Ischemic and Reperfusion Injury: Role of Purine and Adenosine Metabolism -- 31. Ischemic Preconditions in a Model of Isolated Cardiomyocytes -- 32. Integration of Adenosine and Noradrenergic Pathways in Cardiac Preconditioning -- 33. Myocardial Stunning and Preconditioning during Non-cardioplegic Warm Intermittent Aortic Crossclamping -- IV: Purines and Intracellular Calcium -- 34. Energy and Cation Control in the Reoxygenated Myocardial Cell -- 35. Cystolic Calcium Transport during Myocardial Protection -- 36. Future Therapueitc Use of Purines in Myocardial Protection